Virna Borowski

1.0k total citations
7 papers, 335 citations indexed

About

Virna Borowski is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Virna Borowski has authored 7 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Virna Borowski's work include RNA Interference and Gene Delivery (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Click Chemistry and Applications (1 paper). Virna Borowski is often cited by papers focused on RNA Interference and Gene Delivery (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Click Chemistry and Applications (1 paper). Virna Borowski collaborates with scholars based in United States, Israel and Netherlands. Virna Borowski's co-authors include Mary Mehlig, Gerrit Borchard, Hong Zhao, Jeannene Butler, Lee M. Greenberger, Yun H. Choe, R. B. GREENWALD, Pooja Chandna, David Filpula and Karen Yang and has published in prestigious journals such as Journal of Controlled Release, Molecular Pharmacology and Molecular Cancer Therapeutics.

In The Last Decade

Virna Borowski

7 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Virna Borowski United States 7 199 101 89 68 53 7 335
Prakash Sai India 6 242 1.2× 86 0.9× 121 1.4× 42 0.6× 53 1.0× 8 386
M. Farao Italy 7 236 1.2× 128 1.3× 166 1.9× 45 0.7× 72 1.4× 9 399
Mary Mehlig United States 7 299 1.5× 102 1.0× 164 1.8× 75 1.1× 60 1.1× 9 473
Toshiyuki Suzawa Japan 12 212 1.1× 65 0.6× 41 0.5× 95 1.4× 43 0.8× 25 351
Marina Ripamonti Italy 11 237 1.2× 105 1.0× 92 1.0× 112 1.6× 104 2.0× 18 467
Kuangshi Wu United States 7 183 0.9× 85 0.8× 205 2.3× 71 1.0× 79 1.5× 10 384
James R. Kintzing United States 7 481 2.4× 86 0.9× 100 1.1× 131 1.9× 55 1.0× 10 639
Doreen Kunze Germany 10 225 1.1× 110 1.1× 71 0.8× 29 0.4× 39 0.7× 14 475
Shi Xu United States 5 241 1.2× 77 0.8× 217 2.4× 61 0.9× 23 0.4× 5 492
Kiran R. Chaudhari India 7 253 1.3× 129 1.3× 255 2.9× 87 1.3× 25 0.5× 8 529

Countries citing papers authored by Virna Borowski

Since Specialization
Citations

This map shows the geographic impact of Virna Borowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virna Borowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virna Borowski more than expected).

Fields of papers citing papers by Virna Borowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virna Borowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virna Borowski. The network helps show where Virna Borowski may publish in the future.

Co-authorship network of co-authors of Virna Borowski

This figure shows the co-authorship network connecting the top 25 collaborators of Virna Borowski. A scholar is included among the top collaborators of Virna Borowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virna Borowski. Virna Borowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
LaMontagne, Kenneth R., Jeannene Butler, Virna Borowski, et al.. (2009). A highly selective, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor has potent activity in vitro and in vivo. Angiogenesis. 12(3). 287–296. 8 indexed citations
2.
Emanuel, Stuart L., Terry V. Hughes, Mary Adams, et al.. (2007). Cellular and in Vivo Activity of JNJ-28871063, A Nonquinazoline Pan-ErbB Kinase Inhibitor That Crosses the Blood-Brain Barrier and Displays Efficacy against Intracranial Tumors. Molecular Pharmacology. 73(2). 338–348. 30 indexed citations
3.
Zhao, Hong, Ping Peng, Clifford Longley, et al.. (2006). Delivery of G3139 using releasable PEG-linkers: Impact on pharmacokinetic profile and anti-tumor efficacy. Journal of Controlled Release. 119(2). 143–152. 17 indexed citations
4.
Rugg, Catherine A., Stuart L. Emanuel, Anna Maria Calcagno, et al.. (2006). Role of the ABCG2 drug transporter in the resistance and oral bioavailability of a potent cyclin-dependent kinase/Aurora kinase inhibitor. Molecular Cancer Therapeutics. 5(10). 2459–2467. 47 indexed citations
5.
Yu, Deshan, Ping Peng, S. Dharap, et al.. (2005). Antitumor activity of poly(ethylene glycol)–camptothecin conjugate: The inhibition of tumor growth in vivo. Journal of Controlled Release. 110(1). 90–102. 95 indexed citations
6.
Yang, Kaiyong, Anirban Basu, H. Wang, et al.. (2003). Tailoring structure-function and pharmacokinetic properties of single-chain Fv proteins by site-specific PEGylation. Protein Engineering Design and Selection. 16(10). 761–770. 86 indexed citations
7.
Choe, Yun H., Cheryl A. Conover, Dee Wu, et al.. (2002). Anticancer drug delivery systems: multi-loaded N4-acyl poly(ethylene glycol) prodrugs of ara-C.II. Efficacy in ascites and solid tumors. Journal of Controlled Release. 79(1-3). 55–70. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026